5-hydroxytryptamine (serotonin) receptor 2C |
SECOBARBITAL |
Serotonin 5-HT2C |
-18% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
TETRACYCLINE |
Glutamate, AMPA |
-18% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA2 |
TETRACYCLINE |
Glutamate, AMPA |
-18% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA3 (alpha 3) |
TETRACYCLINE |
Glutamate, AMPA |
-18% |
NoneNone |
NoneNone |
View
|
glutamate receptor subunit 4c |
TETRACYCLINE |
Glutamate, AMPA |
-18% |
NoneNone |
NoneNone |
View
|
neuropeptide Y receptor Y2 |
TETRACYCLINE |
Neuropeptide Y2 |
-18% |
NoneNone |
NoneNone |
View
|
neuropeptide Y receptor Y2 |
TETRACYCLINE |
Neuropeptide Y2 |
-18% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 5 |
6-MERCAPTOPURINE |
Glutamate, Kainate |
-18% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 4 |
6-MERCAPTOPURINE |
Glutamate, Kainate |
-18% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 3 |
6-MERCAPTOPURINE |
Glutamate, Kainate |
-18% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
AMBROXOL |
Cyclooxygenase COX-1 |
-18% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
SULFAMERAZINE |
Cyclooxygenase COX-1 |
-18% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
SULFAMERAZINE |
Cyclooxygenase COX-1 |
-18% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 5 |
EPINEPHRINE |
Chemokine CCR5 |
-18% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 5 |
GLYBURIDE |
Chemokine CCR5 |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
BETAMIPRON |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
BETAMIPRON |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
BETAMIPRON |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
BETAMIPRON |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
BETAMIPRON |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
BETAMIPRON |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
BETAMIPRON |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
BETAMIPRON |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
BETAMIPRON |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
BETAMIPRON |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
BETAMIPRON |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
BETAMIPRON |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
BETAMIPRON |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
protein phosphatase 3, catalytic subunit, beta isoform |
PRIMAQUINE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-19% |
NoneNone |
NoneNone |
View
|
bM410K19.2.2 (novel protein similar to extra-cellular matrix proteins and chondroitin sulfate proteoglycans, variant 2) (DBSS) |
PRIMAQUINE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-19% |
NoneNone |
NoneNone |
View
|
epidermal growth factor receptor |
CARMOFUR |
Protein Tyrosine Kinase, EGF Receptor |
-19% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
CETYLPYRIDINIUM BROMIDE |
beta-Lactamase |
-19% |
NoneNone |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
L-CAMPHOR |
Protein Tyrosine Kinase, HER2 Receptor |
-19% |
NoneNone |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
L-CAMPHOR |
Protein Tyrosine Kinase, HER2 Receptor |
-19% |
NoneNone |
NoneNone |
View
|
interleukin 1 receptor, type I |
SIBUTRAMINE |
Interleukin IL-1 alpha |
-19% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 1 |
CANTHARIDIN |
Adrenergic beta1 |
-19% |
NoneNone |
NoneNone |
View
|
adrenergic, beta-1-, receptor |
CANTHARIDIN |
Adrenergic beta1 |
-19% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
PROGLUMIDE |
Adrenergic, Norepinephrine Transporter |
-19% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 9 |
PODOPHYLLOTOXIN |
Nicotinic Acetylcholine, Central |
-19% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 10 |
PODOPHYLLOTOXIN |
Nicotinic Acetylcholine, Central |
-19% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, epsilon polypeptide |
PODOPHYLLOTOXIN |
Nicotinic Acetylcholine, Central |
-19% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, beta polypeptide 4 |
PODOPHYLLOTOXIN |
Nicotinic Acetylcholine, Central |
-19% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 5 |
PODOPHYLLOTOXIN |
Nicotinic Acetylcholine, Central |
-19% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) |
PODOPHYLLOTOXIN |
Nicotinic Acetylcholine, Central |
-19% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
STANOZOLOL |
Glutamate, NMDA, Agonism |
-19% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, NMDA2C |
STANOZOLOL |
Glutamate, NMDA, Agonism |
-19% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
STANOZOLOL |
Glutamate, NMDA, Agonism |
-19% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
STANOZOLOL |
Glutamate, NMDA, Agonism |
-19% |
NoneNone |
NoneNone |
View
|
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
STANOZOLOL |
Glutamate, NMDA, Agonism |
-19% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
STANOZOLOL |
Glutamate, NMDA, Agonism |
-19% |
NoneNone |
NoneNone |
View
|
insulin receptor |
BENZETHONIUM CHLORIDE |
Insulin |
-19% |
NoneNone |
NoneNone |
View
|
insulin receptor |
BENZETHONIUM CHLORIDE |
Insulin |
-19% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 3 |
CANDESARTAN |
Glycine, Strychnine-Sensitive |
-19% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 1 subunit |
CANDESARTAN |
Glycine, Strychnine-Sensitive |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
ACECLOFENAC |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
ACECLOFENAC |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
ACECLOFENAC |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
ACECLOFENAC |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
ACECLOFENAC |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
ACECLOFENAC |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
ACECLOFENAC |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
ACECLOFENAC |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
ACECLOFENAC |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
ACECLOFENAC |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
ACECLOFENAC |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
ACECLOFENAC |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
ACECLOFENAC |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
MADURAMICIN |
Serotonin 5-HT2C |
-19% |
NoneNone |
NoneNone |
View
|
aldo-keto reductase family 1, member B4 (aldose reductase) |
MADURAMICIN |
Aldose Reductase |
-19% |
NoneNone |
NoneNone |
View
|
aldo-keto reductase family 1, member B1 (aldose reductase) |
MADURAMICIN |
Aldose Reductase |
-19% |
NoneNone |
NoneNone |
View
|
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) |
MADURAMICIN |
Aldose Reductase |
-19% |
NoneNone |
NoneNone |
View
|
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) |
MADURAMICIN |
Aldose Reductase |
-19% |
NoneNone |
NoneNone |
View
|
interleukin 8 receptor, beta |
NIFLUMIC ACID |
Chemokine CXCR2 (IL-8B) |
-19% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 9 |
NORTRIPTYLINE |
Nicotinic Acetylcholine, Central |
-19% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 10 |
NORTRIPTYLINE |
Nicotinic Acetylcholine, Central |
-19% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, epsilon polypeptide |
NORTRIPTYLINE |
Nicotinic Acetylcholine, Central |
-19% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, beta polypeptide 4 |
NORTRIPTYLINE |
Nicotinic Acetylcholine, Central |
-19% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 5 |
NORTRIPTYLINE |
Nicotinic Acetylcholine, Central |
-19% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 1a |
GLICLAZIDE |
Adrenergic alpha1A |
-18% |
NoneNone |
NoneNone |
View
|
cannabinoid receptor 1 (brain) |
PROPYLTHIOURACIL |
Cannabinoid CB1 |
-18% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 3 |
LEVODOPA |
Protein Serine/Threonine Kinase, ERK1 |
-18% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 3 |
LEVODOPA |
Protein Serine/Threonine Kinase, ERK1 |
-18% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
IRINOTECAN |
Monoamine Oxidase MAOA |
-18% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
IRINOTECAN |
Monoamine Oxidase MAOA |
-18% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA2 |
ZILEUTON |
Glutamate, AMPA |
-18% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA3 (alpha 3) |
ZILEUTON |
Glutamate, AMPA |
-18% |
NoneNone |
NoneNone |
View
|
progesterone receptor |
LAMOTRIGINE |
Progesterone |
-18% |
NoneNone |
NoneNone |
View
|
progesterone receptor |
LAMOTRIGINE |
Progesterone |
-18% |
NoneNone |
NoneNone |
View
|
arginine vasopressin receptor 1A |
R-(+)-PROPRANOLOL |
Vasopressin V1A |
-18% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 3 |
TRIAMTERENE |
Protein Serine/Threonine Kinase, ERK1 |
-18% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 3 |
TRIAMTERENE |
Protein Serine/Threonine Kinase, ERK1 |
-18% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
TRAZODONE |
Cyclooxygenase COX-1 |
-18% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
TRAZODONE |
Cyclooxygenase COX-1 |
-18% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 14 |
HALOPERIDOL |
Protein Serine/Threonine Kinase, p38alpha |
-18% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 14 |
HALOPERIDOL |
Protein Serine/Threonine Kinase, p38alpha |
-18% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
PHENINDIONE |
Protein Serine/Threonine Kinase PKCalpha |
-18% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
PHENINDIONE |
Protein Serine/Threonine Kinase PKCalpha |
-18% |
NoneNone |
NoneNone |
View
|
interleukin 8 receptor, alpha |
MONOBENZONE |
Chemokine CXCR1(IL-8A) |
-18% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 |
MONOBENZONE |
Thromboxane Synthetase |
-18% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
MONOBENZONE |
Thromboxane Synthetase |
-18% |
NoneNone |
NoneNone |
View
|
neuropeptide Y receptor Y1 |
GENISTEIN |
Neuropeptide Y1 |
-18% |
NoneNone |
NoneNone |
View
|
natriuretic peptide receptor 2 |
GENTIAN VIOLET |
Atrial Natriuretic Factor (ANF) |
-18% |
NoneNone |
NoneNone |
View
|
guanylate cyclase A/atrial natriuretic peptide receptor (Non-specific probe) |
GENTIAN VIOLET |
Atrial Natriuretic Factor (ANF) |
-18% |
NoneNone |
NoneNone |
View
|
natriuretic peptide receptor 3 |
GENTIAN VIOLET |
Atrial Natriuretic Factor (ANF) |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
TRIAMTERENE |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
TRIAMTERENE |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
TRIAMTERENE |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
TRIAMTERENE |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
TRIAMTERENE |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
TRIAMTERENE |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
TRIAMTERENE |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
TRIAMTERENE |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
TRIAMTERENE |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
TRIAMTERENE |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
TRIAMTERENE |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
TRIAMTERENE |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
TRIAMTERENE |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
TRIAMTERENE |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
TRIAMTERENE |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
TRIAMTERENE |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
TRIAMTERENE |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
TRIAMTERENE |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
TRIAMTERENE |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
TRIAMTERENE |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 5 (DBSS) |
ISOEUGENOL |
Tumor Necrosis Factor (TNF), Non-Selective |
-18% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 1b |
ISOEUGENOL |
Tumor Necrosis Factor (TNF), Non-Selective |
-18% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 1a |
ISOEUGENOL |
Tumor Necrosis Factor (TNF), Non-Selective |
-18% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 4 |
ISOEUGENOL |
Tumor Necrosis Factor (TNF), Non-Selective |
-18% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) |
ISOEUGENOL |
Tumor Necrosis Factor (TNF), Non-Selective |
-18% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 8 |
ISOEUGENOL |
Tumor Necrosis Factor (TNF), Non-Selective |
-18% |
NoneNone |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
ISOTRETINOIN |
Protein Tyrosine Kinase, Fyn |
-18% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
CIMETIDINE |
Leukotriene B4 |
-18% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
CIMETIDINE |
Leukotriene B4 |
-18% |
NoneNone |
NoneNone |
View
|
interleukin 8 receptor, alpha |
CIMETIDINE |
Chemokine CXCR1(IL-8A) |
-18% |
NoneNone |
NoneNone |
View
|
androgen receptor |
TRIMETHADIONE |
Testosterone |
-18% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
BETAMETHASONE PHOSPHATE |
Leukotriene C4 Synthetase |
-18% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
BETAMETHASONE PHOSPHATE |
Leukotriene C4 Synthetase |
-18% |
NoneNone |
NoneNone |
View
|
cholecystokinin A receptor |
BETAMETHASONE PHOSPHATE |
Cholecystokinin CCKA |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
CINNAMALDEHYDE |
Calcium Channel Type L, Benzothiazepine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
CINNAMALDEHYDE |
Calcium Channel Type L, Benzothiazepine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
CINNAMALDEHYDE |
Calcium Channel Type L, Benzothiazepine |
-18% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 2 |
PHENOTHIAZINE |
GABAA, Benzodiazepine, Central |
-18% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 1 |
PHENOTHIAZINE |
GABAA, Benzodiazepine, Central |
-18% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
PHENOTHIAZINE |
GABAA, Benzodiazepine, Central |
-18% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
PHENOTHIAZINE |
GABAA, Benzodiazepine, Central |
-18% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, delta |
PHENOTHIAZINE |
GABAA, Benzodiazepine, Central |
-18% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
PHENOTHIAZINE |
GABAA, Benzodiazepine, Central |
-18% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase 5a, mitochondrial |
INSULIN |
Carbonic Anhydrase |
-18% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase 3 |
INSULIN |
Carbonic Anhydrase |
-18% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase 2 |
INSULIN |
Carbonic Anhydrase |
-18% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase 4 |
INSULIN |
Carbonic Anhydrase |
-18% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase XI |
INSULIN |
Carbonic Anhydrase |
-18% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase IX |
INSULIN |
Carbonic Anhydrase |
-18% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase VIII |
INSULIN |
Carbonic Anhydrase |
-18% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase VII |
INSULIN |
Carbonic Anhydrase |
-18% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase VA, mitochondrial |
INSULIN |
Carbonic Anhydrase |
-18% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase IV |
INSULIN |
Carbonic Anhydrase |
-18% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase III, muscle specific |
INSULIN |
Carbonic Anhydrase |
-18% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase I |
INSULIN |
Carbonic Anhydrase |
-18% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase XIV |
INSULIN |
Carbonic Anhydrase |
-18% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase VB, mitochondrial |
INSULIN |
Carbonic Anhydrase |
-18% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase XII |
INSULIN |
Carbonic Anhydrase |
-18% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase VI |
INSULIN |
Carbonic Anhydrase |
-18% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase II |
INSULIN |
Carbonic Anhydrase |
-18% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 3 |
ETHANOL |
Adrenergic beta3 |
-18% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
RANITIDINE |
Leukotriene B4 |
-18% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
RANITIDINE |
Leukotriene B4 |
-18% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
RANITIDINE |
Leukotriene B4 |
-18% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
RANITIDINE |
Leukotriene B4 |
-18% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
INSULIN |
Leukotriene B4 |
-18% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
INSULIN |
Leukotriene B4 |
-18% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
INSULIN |
Leukotriene B4 |
-18% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
INSULIN |
Leukotriene B4 |
-18% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 14 |
CELECOXIB |
Protein Serine/Threonine Kinase, p38alpha |
-18% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 14 |
CELECOXIB |
Protein Serine/Threonine Kinase, p38alpha |
-18% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2b |
CEPHALEXIN |
Adrenergic alpha2C |
-18% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
CEPHALEXIN |
Adrenergic alpha2C |
-18% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 1 |
ETHANOL |
Muscarinic M1 |
-18% |
NoneNone |
NoneNone |
View
|
platelet-activating factor receptor |
INSULIN |
Platelet Activating Factor (PAF) |
-18% |
NoneNone |
NoneNone |
View
|
cathepsin G |
TIRILAZAD |
Protease, Cathepsin G |
-18% |
NoneNone |
NoneNone |
View
|
mast cell protease 9 |
TIRILAZAD |
Protease, Cathepsin G |
-18% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
TIRILAZAD |
beta-Lactamase |
-18% |
NoneNone |
NoneNone |
View
|
adenosine A1 receptor |
CERIVASTATIN |
Adenosine A1 |
-18% |
NoneNone |
NoneNone |
View
|
nitric oxide synthase 2A (inducible, hepatocytes) |
CYCLOSPORIN A |
Nitric Oxide Synthase, Inducible (iNOS) |
-18% |
NoneNone |
NoneNone |
View
|
nitric oxide synthase 2, inducible |
CYCLOSPORIN A |
Nitric Oxide Synthase, Inducible (iNOS) |
-18% |
NoneNone |
NoneNone |
View
|
arginine vasopressin receptor 1A |
CYCLOSPORIN A |
Vasopressin V1A |
-18% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 |
CYCLOSPORIN A |
Thromboxane Synthetase |
-18% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
CYCLOSPORIN A |
Thromboxane Synthetase |
-18% |
NoneNone |
NoneNone |
View
|
aldo-keto reductase family 1, member B4 (aldose reductase) |
CYCLOSPORIN A |
Aldose Reductase |
-18% |
NoneNone |
NoneNone |
View
|
aldo-keto reductase family 1, member B1 (aldose reductase) |
CYCLOSPORIN A |
Aldose Reductase |
-18% |
NoneNone |
NoneNone |
View
|
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) |
CYCLOSPORIN A |
Aldose Reductase |
-18% |
NoneNone |
NoneNone |
View
|
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) |
CYCLOSPORIN A |
Aldose Reductase |
-18% |
NoneNone |
NoneNone |
View
|
neuropeptide Y receptor Y1 |
TIRILAZAD |
Neuropeptide Y1 |
-18% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 1 |
TIRILAZAD |
Protein Serine/Threonine Kinase, ERK2 |
-18% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 1 |
TIRILAZAD |
Protein Serine/Threonine Kinase, ERK2 |
-18% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-1A2 monooxygenase |
CLEMASTINE |
CYP450-1A2 Inhibition |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
BETAMIPRON |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
BETAMIPRON |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
BETAMIPRON |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
BETAMIPRON |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|